Evidence map›Paper›PMID 37238237›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Painless Capillary Blood Collection: A Rapid Evaluation of the Onflow Device.

Lara Dominique Noble, Caitlin Dixon, Alison Moran, Charlotte Trottet, Mohammed Majam, Shameema Ismail, Vanessa Tiyamike Msolomba, Kegomoditswe Mathobela, Arthur Queval, Jaya George and 2 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. A Bioinspired and Cost-Effective Device for Minimally Invasive Blood Sampling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lara Dominique NobleWITS Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg 2000, South Africa.ORCID 0000-0002-4661-9023
Caitlin DixonWITS Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg 2000, South Africa.ORCID 0000-0001-5868-2903
Alison MoranLoop Medical SA, 1015 Lausanne, Vaud, Switzerland.
Charlotte TrottetLoop Medical SA, 1015 Lausanne, Vaud, Switzerland.ORCID 0009-0003-4034-262X
Mohammed MajamEzintsha, a Sub-Division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg 2000, South Africa.ORCID 0000-0003-0302-5353
Shameema IsmailEzintsha, a Sub-Division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg 2000, South Africa.
Vanessa Tiyamike MsolombaEzintsha, a Sub-Division of Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg 2000, South Africa.ORCID 0000-0002-4063-7167
Kegomoditswe MathobelaWITS Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg 2000, South Africa.
Arthur QuevalLoop Medical SA, 1015 Lausanne, Vaud, Switzerland.
Jaya GeorgeWITS Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg 2000, South Africa.
Lesley Erica ScottWITS Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg 2000, South Africa.
Wendy Susan StevensWITS Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg 2000, South Africa.
University of the Witwatersrand · ZANational Health Laboratory Service · ZA

Funding

Bill & Melinda Gates Foundation INV-006726Bill & Melinda Gates Foundation INV-008063
6 · The paper itself

Abstract

Blood-based diagnostics are critical for many medical decisions, but mostly rely on venepuncture, which can be inconvenient and painful. The Onflow Serum Gel (Loop Medical SA, Vaud, Lausanne, Switzerland) is a novel blood collection device that utilises needle-free technology to collect capillary blood. In this pilot study, 100 healthy participants were enrolled and provided two Onflow collected specimens and one venous blood specimen. Five chemistry analytes (AST, ALT, LDH, potassium, creatinine) and haemolysis were measured per specimen, and laboratory analyte results were compared. Onflow was found to be more acceptable than venepuncture with lower pain ratings, and 96.5% of participants would use the Onflow method again. All phlebotomists (100%) found Onflow intuitive and user-friendly, with ~1 mL of Onflow blood successfully collected from 99% of participants in <12 min (mean: 6 min, 40 s) and 91% collected on the first attempt. ALT and AST analytes showed no difference in performance, while creatinine generated a negative bias (-5.6 µmol/L), and increased variability was noted with potassium (3.6%CV) and LDH (6.7%CV), although none were clinically relevant. These differences may be due to 35% of Onflow collected specimens having "mild" haemolysis. Onflow is a promising alternative blood collection device that should now be evaluated in participants with expected abnormal chemistries and as an option for self-collection.

Indexed as

capillary blood collectiononflow serum gelpain-freeserum chemistryupper arm collection devicevenous-comparable blood specimen

Identifiers

PMID37238237
PMCPMC10217062
OpenAlexW4377041325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.